The Final Privacy Rule requires a covered entity to obtain an individual's prior written authorization to use his or her PHI for marketing purposes except for:
A.
Situations where the marketing is for a drug or treatment could improve the health of that individual.
B.
Situations where the patient has already signed the covered entity's Notice of Privacy Practices.
C.
A face-to-face encounter with the sales person of a company that provides drug samples
D.
A communication involving a promotional gift of nominal value.
E.
The situation where the patient has signed the Notice of Privacy Practices of the marketer.
Chosen Answer:
This is a voting comment (?). You can switch to a simple comment. It is better to Upvote an existing comment if you don't have anything to add.
Submit